Laerdal
Deals on record
1
Common Fundraising Type
Series B
CorFlow Therapeutics
Microvascular Obstruction
CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.